Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Bloodstream infection with carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Acinetobacter baumannii: a case report.

Zhang HM, Liu DW, Wang XT, Long Y, Chen H.

Chin Med Sci J. 2014 Mar;29(1):51-4.

PMID:
24698680
[PubMed - indexed for MEDLINE]
2.

In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.

Urban C, Mariano N, Rahal JJ.

Antimicrob Agents Chemother. 2010 Jun;54(6):2732-4. doi: 10.1128/AAC.01768-09. Epub 2010 Apr 5.

PMID:
20368401
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.

Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, Ecker DJ, Adams MD, Toltzis P, Dul MJ, Windau A, Bajaksouzian S, Jacobs MR, Salata RA, Bonomo RA.

J Antimicrob Chemother. 2010 Aug;65(8):1807-18. doi: 10.1093/jac/dkq191. Epub 2010 May 31.

PMID:
20513702
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.

Munoz-Price LS, Zembower T, Penugonda S, Schreckenberger P, Lavin MA, Welbel S, Vais D, Baig M, Mohapatra S, Quinn JP, Weinstein RA.

Infect Control Hosp Epidemiol. 2010 Oct;31(10):1057-62. doi: 10.1086/656247.

PMID:
20715975
[PubMed - indexed for MEDLINE]
5.

Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V, Vrettou C, Paniara O, Giamarellou H, Roussos C.

Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.

PMID:
20224962
[PubMed - indexed for MEDLINE]
6.

Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.

Esterly JS, Griffith M, Qi C, Malczynski M, Postelnick MJ, Scheetz MH.

Antimicrob Agents Chemother. 2011 Oct;55(10):4844-9. doi: 10.1128/AAC.01728-10. Epub 2011 Aug 8.

PMID:
21825287
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.

Clock SA, Tabibi S, Alba L, Kubin CJ, Whittier S, Saiman L.

Diagn Microbiol Infect Dis. 2013 Jul;76(3):343-6. doi: 10.1016/j.diagmicrobio.2013.03.014. Epub 2013 Apr 17.

PMID:
23601454
[PubMed - indexed for MEDLINE]
8.

Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.

Anunnatsiri S, Tonsawan P.

Southeast Asian J Trop Med Public Health. 2011 May;42(3):693-703.

PMID:
21706949
[PubMed - indexed for MEDLINE]
9.

Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens.

Poulakou G, Kontopidou FV, Paramythiotou E, Kompoti M, Katsiari M, Mainas E, Nicolaou C, Yphantis D, Antoniadou A, Trikka-Graphakos E, Roussou Z, Clouva P, Maguina N, Kanellakopoulou K, Armaganidis A, Giamarellou H.

J Infect. 2009 Apr;58(4):273-84. doi: 10.1016/j.jinf.2009.02.009.

PMID:
19344841
[PubMed - indexed for MEDLINE]
10.

Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy.

Kim YJ, Kim SI, Hong KW, Kim YR, Park YJ, Kang MW.

J Korean Med Sci. 2012 May;27(5):471-5. doi: 10.3346/jkms.2012.27.5.471. Epub 2012 Apr 25.

PMID:
22563209
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.

Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M.

J Hosp Infect. 2006 Nov;64(3):282-7. Epub 2006 Aug 22.

PMID:
16930770
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.

Cunha BA.

J Clin Microbiol. 2009 May;47(5):1613. doi: 10.1128/JCM.00404-09. No abstract available.

PMID:
19403778
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii.

Martins N, Martins IS, de Freitas WV, de Matos JA, Magalhães AC, Girão VB, Dias RC, de Souza TC, Pellegrino FL, Costa LD, Boasquevisque CH, Nouér SA, Riley LW, Santoro-Lopes G, Moreira BM.

Transpl Infect Dis. 2012 Jun;14(3):316-20. doi: 10.1111/j.1399-3062.2011.00701.x. Epub 2011 Dec 14.

PMID:
22168176
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.

Huang ST, Chiang MC, Kuo SC, Lee YT, Chiang TH, Yang SP, Ti-Yin, Chen TL, Fung CP.

J Microbiol Immunol Infect. 2012 Oct;45(5):356-62. doi: 10.1016/j.jmii.2011.12.009. Epub 2012 May 9.

PMID:
22575430
[PubMed - indexed for MEDLINE]
15.

Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance.

Katsaragakis S, Markogiannakis H, Toutouzas KG, Drimousis P, Larentzakis A, Theodoraki EM, Theodorou D.

World J Surg. 2008 Jun;32(6):1194-202. doi: 10.1007/s00268-008-9571-3.

PMID:
18408967
[PubMed - indexed for MEDLINE]
16.

Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.

Nguyen M, Eschenauer GA, Bryan M, O'Neil K, Furuya EY, Della-Latta P, Kubin CJ.

Diagn Microbiol Infect Dis. 2010 Jun;67(2):180-4. doi: 10.1016/j.diagmicrobio.2010.02.001. Epub 2010 Mar 31.

PMID:
20356699
[PubMed - indexed for MEDLINE]
17.

Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.

Kim SY, Jung JY, Kang YA, Lim JE, Kim EY, Lee SK, Park SC, Chung KS, Park BH, Kim YS, Kim SK, Chang J, Park MS.

J Korean Med Sci. 2012 Aug;27(8):939-47. doi: 10.3346/jkms.2012.27.8.939. Epub 2012 Jul 25.

PMID:
22876063
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.

Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A.

Int J Antimicrob Agents. 2008 Nov;32(5):450-4. doi: 10.1016/j.ijantimicag.2008.05.016. Epub 2008 Sep 2.

PMID:
18768302
[PubMed - indexed for MEDLINE]
19.

Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.

Park YK, Jung SI, Park KH, Kim DH, Choi JY, Kim SH, Ko KS.

J Med Microbiol. 2012 Jan;61(Pt 1):71-9. doi: 10.1099/jmm.0.033852-0. Epub 2011 Aug 18.

PMID:
21852525
[PubMed - indexed for MEDLINE]
20.

Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.

Roy S, Viswanathan R, Singh A, Das P, Basu S.

Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1495-500. doi: 10.1007/s10096-010-1030-z. Epub 2010 Aug 21.

PMID:
20730467
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk